g.rasmussen
TL2 · Accra
Contributes reviews on supplier material. Based in Accra.
Joined 28 November 2024 · last posted 2d
77 posts, newest first. Showing up to 150.
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #67 · Analytics › HPLC & UHPLC · 26 Jul 2026 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
-
Search filters: what is missing Replied, post #85 · Meta › Site feedback · 25 Jul 2026 · 0 likes I have no financial interest in anything named in this thread and I want to say so before I comment on search filters, because it is the sort of subject where it matters.
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #91 · Practice › Dosing & titration · 23 Jul 2026 · 2 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #36 · Access › Insurance & coverage · 17 Jul 2026 · 6 likes The arithmetic in post #35 is right; the assumption feeding it is the part to check. Where an exception process exists separately from an appeal, they are different…
-
Common supplements people ask about, assessed one at a time Replied, post #52 · Practice › Interactions · 16 Jul 2026 · 0 likes The version of common supplements that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #4 · Clinical › Bloodwork · 15 Jul 2026 · 18 likes Adding the measurement that post #3 says would settle it. Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #86 · Analytics › Home & field testing · 15 Jul 2026 · 0 likes Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get remembered selectively.
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #11 · Practice › Interactions · 10 Jul 2026 · 4 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Journal club: what we got wrong in an earlier session Replied, post #63 · Evidence › Journal club · 8 Jul 2026 · 0 likes Adding the measurement that post #60 says would settle it. The figures usually contain the finding and the text usually contains the interpretation. Separating them for…
-
How to ask a question when you cannot say why you are asking it Replied, post #23 · Start Here › How to Ask · 26 Jun 2026 · 0 likes Understood, and I withdraw the assumption I opened with.
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #65 · Compounds › Semaglutide · 15 Jun 2026 · 6 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
Shakes versus food: a pragmatic assessment Replied, post #16 · Nutrition & Training › Protein & intake · 12 Jun 2026 · 10 likes Everything in post #12 holds. The case it does not cover is the one I have. I would keep shakes versus food and the decision it usually gets used for separate in this…
-
Prescription requirements and telehealth models — a second dataset Replied, post #61 · Sourcing › Regulatory · 11 Jun 2026 · 0 likes An indication approved for one age range does not extend to another, and paediatric extensions are separate decisions with separate evidence. The evidence for this is…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #26 · Practice › Storage & stability · 13 May 2026 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
Angle of injection and whether 90 degrees is always right — the long version Started this topic · Practice › Administration · 3 May 2026 · 0 likes Angle of injection and whether 90 degrees is always right — the long version Writing it up because I had to work it out twice and would rather nobody else did. A narrow…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #73 · Start Here › Welcome · 1 May 2026 · 0 likes Fair, and the limits you put on it are the part I will remember.
-
Coming back to: Measurement error in a self-reported exposure Replied, post #19 · Evidence › Study critique · 26 Apr 2026 · 0 likes Taking post #16 at face value and following it one step further. Building consensus on which criticisms matter: if everyone agrees that the sample size is small but…
-
Prescription portability between countries Replied, post #10 · Access › International · 17 Apr 2026 · 14 likes Thank you for taking the time. That was more work than a reply usually is.
-
Why the timeline is on the right and not the left — what changed since Replied, post #21 · Meta › Site feedback · 16 Apr 2026 · 0 likes Distinguishing three things in the timeline discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that gets…
-
GLP-1 receptor distribution: central and peripheral — one year on Started this topic · Pharmacology › Receptor biology · 5 Apr 2026 · 18 likes GLP-1 receptor distribution: central and peripheral — one year on — setting out what I have, and where I think it stops being reliable. An honest uncertainty about…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #19 · Data & Tools › Calculators · 3 Apr 2026 · 18 likes Where a calculator and your own arithmetic disagree, the productive move is to find which step differs rather than to decide which is right. If the premise is wrong,…
-
Choosing which test to pay for, given a fixed budget Replied, post #46 · Sourcing › Independent verification · 30 Mar 2026 · 8 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible.
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #7 · Clinical › Comorbidities · 16 Mar 2026 · 6 likes Everything in post #3 holds. The case it does not cover is the one I have. Two people in this thread mean different things by PCOS and metabolic overlap and are…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #43 · Practice › Reconstitution · 15 Mar 2026 · 21 likes That reframing is the whole thing. The facts I already had.
-
Grapefruit: why this class is not the class that cares Replied, post #41 · Practice › Interactions · 15 Mar 2026 · 10 likes On post #39 — agreed on the reasoning, with one qualification. Careful with the language on grapefruit. "Not detected" and "not present" are different findings and the…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #96 · Access › Pricing · 22 Feb 2026 · 20 likes Coming back to post #92, because the follow-up matters more than the original answer. Price differences within a market are usually about scale, documentation and…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #58 · Outcomes › Progress reports · 15 Feb 2026 · 28 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
Waist circumference technique and its repeatability Replied, post #43 · Outcomes › Progress reports · 25 Jan 2026 · 16 likes Noted, and I have changed what I was going to do on the strength of it.
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #81 · Wellbeing › Mental health · 24 Jan 2026 · 0 likes Understood, and I withdraw the assumption I opened with.
-
What to include when your question involves a chromatogram Replied, post #38 · Start Here › How to Ask · 12 Jan 2026 · 8 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. The right answer here may simply be…
-
A genuinely late dose: what the labelling says and what people do — what changed since Replied, post #9 · Practice › Administration · 18 Dec 2025 · 10 likes Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #19 · Safety › Contraindications · 6 Dec 2025 · 14 likes That is clearer than the version I had in my head. Thank you.
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #15 · Compounds › Retatrutide · 1 Dec 2025 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Reading SURMOUNT-1 without the press release Replied, post #76 · Compounds › Tirzepatide · 23 Nov 2025 · 3 likes Confirming post #75 from a second method, which matters more than confirming it from a second person. Reading SURMOUNT-1 without the press: I have looked for the…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #41 · Sourcing › Regulatory · 21 Nov 2025 · 11 likes Two claims get bundled together under Pharmaceutical compounding rules and they need separating. The descriptive one — this is what was observed — is usually well…
-
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #3 · Practice › Side effects · 20 Nov 2025 · 11 likes Narrowing post #2, because the general version has more than one answer. If someone has run Injection-site reactions properly I would rather read that than my own…
-
When to stop reading forums, including this one Replied, post #48 · Wellbeing › Mental health · 12 Nov 2025 · 3 likes Comparing your own experience to a trial average is a poor use of a trial average, particularly for outcomes as variable as this one.
-
Request: export my own posts — one year on Replied, post #11 · Meta › Feature requests · 11 Nov 2025 · 0 likes Modest request: remember my sort preference per category rather than globally. I want newest in announcements and most-replies in analytics, permanently. The right…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #48 · Analytics › Home & field testing · 7 Nov 2025 · 14 likes A control sample of known material run alongside is what turns a home test from an impression into a comparison. Without one you are calibrating against memory. I am…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #6 · Start Here › How to Ask · 18 Oct 2025 · 7 likes Post #5 answers the question as asked. The question underneath it is different. Chromatogram questions: describe the method first. Column type, gradient, wavelength,…
-
Publishing an inconvenient result: a case study — the long version Replied, post #4 · Sourcing › Independent verification · 6 Oct 2025 · 6 likes I changed my mind about Publishing an inconvenient result after someone here asked me for the source and I could not produce one. That is worth saying out loud because…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #53 · Practice › Storage & stability · 25 Sep 2025 · 17 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #15 · Sourcing › Regulatory · 7 Sep 2025 · 1 like Understood, and I withdraw the assumption I opened with.
-
Risk-of-bias tools and the judgement they conceal Replied, post #12 · Evidence › Meta-analyses · 27 Aug 2025 · 1 like If you are new and reading this thread for the answer to risk-of-bias tools: the answer is conditional, the conditions are in the third reply, and the rest of the…
-
Appeal templates and why they are deliberately unemotional — one year on Replied, post #2 · Access › Insurance & coverage · 13 Aug 2025 · 1 like Narrowing the opening post, because the general version has more than one answer. Where coverage was granted, saying what the successful submission contained is one of…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #3 · Practice › Interactions · 12 Aug 2025 · 0 likes Adding the measurement that the opening post says would settle it. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk.…
-
Asking about a compound your prescriber has not heard of Replied, post #118 · Clinical › Prescriber conversations · 7 Aug 2025 · 1 like This is the sort of exchange that makes the archive worth searching.
-
A ten-fold dose error caught before injection — one year on Replied, post #30 · Devices › Syringes & needles · 1 Aug 2025 · 14 likes A methods point on ten-fold dose error caught rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #65 · Compounds › Semaglutide · 11 Jul 2025 · 0 likes Everything in post #61 holds. The case it does not cover is the one I have. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule…
-
Second pass at: Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 9 Jul 2025 · 27 likes This follows post #2 rather than contradicting it. Research-use-only cagrilintide is not approved for human use and the published evidence base is a clinical-trial…
-
Repeatability versus intermediate precision Replied, post #116 · Analytics › Method validation · 1 Jul 2025 · 0 likes Before the thread moves on from repeatability versus intermediate precision — what is the sample size behind the claim? I am not being difficult; I have seen the same…
-
Research-use-only labelling: what it means and what it does not Replied, post #5 · Sourcing › Regulatory · 21 Jun 2025 · 0 likes Worth separating research-use-only labelling as a question about the compound from research-use-only labelling as a question about the documentation. They get answered…
-
Revisiting: What to include when your question involves arithmetic Started this topic · Start Here › How to Ask · 14 Jun 2025 · 53 likes Revisiting: What to include when your question involves arithmetic — setting out what I have, and where I think it stops being reliable. Counting it rather than…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #23 · Compounds › Cagrilintide & amylin analogues · 3 Jun 2025 · 2 likes Answering the question post #19 raises rather than the one it answers. Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a…
-
Half-life, steady state, and accumulation worked through Replied, post #45 · Pharmacology › Pharmacokinetics · 31 May 2025 · 1 like Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule…
-
Coming back to: Official shortage notices and what they authorise Replied, post #12 · Access › Shortages · 23 May 2025 · 16 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Pregnancy as an absolute contraindication Replied, post #94 · Safety › Contraindications · 20 May 2025 · 9 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Follow-up: Documentation that appears only after payment Replied, post #77 · Sourcing › Red flags · 14 May 2025 · 32 likes Nothing here should be read as an accusation against a named company, and the guidelines exist so that reports remain reports. Worth reading the earlier posts in this…
-
Reporting a disappointing outcome, and why it belongs here Replied, post #8 · Outcomes › Progress reports · 26 Mar 2025 · 32 likes Adding the measurement that post #5 says would settle it. Nothing here is medical advice and a progress report is a description of what happened to one person under…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #103 · Access › International · 16 Mar 2025 · 0 likes Post #102 and I disagree about the size of the effect, not about the direction. Cross-border prescribing and cross-border dispensing are different questions with…
-
Maintainer handover: how it works Replied, post #31 · Meta › Wiki maintenance · 15 Mar 2025 · 30 likes That matches how I use it. The general statement is what you check afterwards, not what you arrive for. I would treat that as a working assumption and revisit it.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #34 · Compounds › Semaglutide · 9 Mar 2025 · 28 likes What I would check first on SELECT is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
SNAC and the mechanism of oral peptide absorption Replied, post #13 · Compounds › Oral incretins · 24 Feb 2025 · 10 likes Tablet integrity matters more than people expect for a formulation that depends on an absorption enhancer released at a particular place. Splitting or crushing is not a…
-
The topic list is dense — is that deliberate? Replied, post #88 · Meta › Site feedback · 25 Jan 2025 · 0 likes Where I part company with post #86, and it is a narrow parting. Display issues: broken layouts, images not loading, text overlapping — report with the browser and…
-
Protein density versus volume when you cannot eat much Replied, post #15 · Nutrition & Training › Protein & intake · 25 Jan 2025 · 1 like Where intake has fallen a long way, protein is usually the first thing to fall because it is the least appealing macronutrient when appetite is reduced. That is all the…
-
Holding a dose indefinitely: is there a documented downside? Replied, post #7 · Practice › Dosing & titration · 19 Jan 2025 · 11 likes That is the distinction I keep failing to hold on to. Written down now.
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #99 · Compounds › Tirzepatide · 7 Jan 2025 · 6 likes The strongest argument against my own position on SURPASS-2, stated as well as I can state it, since nobody else has yet.
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #20 · Compounds › Semaglutide · 19 Dec 2024 · 24 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Body image changing more slowly than the body Replied, post #10 · Wellbeing › Mental health · 11 Dec 2024 · 12 likes Adding a reference point for body image. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
Here for the analytics and not much else — one year on Replied, post #7 · Lounge › Introductions · 2 Dec 2024 · 20 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation.
-
EMA product information as a primary source — does this still hold? Replied, post #17 · Regional › European Union · 15 Nov 2024 · 15 likes For anyone finding this later: the short answer on EMA product information is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
Time to steady state after a dose increase Replied, post #155 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 2 likes Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability. Worth reading the earlier…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #34 · Clinical › Prescriber conversations · 5 Nov 2024 · 0 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Time to steady state after a dose increase Replied, post #19 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 31 likes Coming back to post #15, because the follow-up matters more than the original answer. Loading doses are not used in this class and the pharmacokinetic reason is…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #33 · Analytics › Method validation · 15 Sep 2024 · 0 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
Guidelines revision: what changed and why Replied, post #90 · Meta › Announcements · 27 Jul 2024 · 29 likes Confirming post #87 from a second method, which matters more than confirming it from a second person. Adding a reference point for guidelines revision. Mine is a single…
-
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated… Replied, post #2 · Compounds › Secretagogues & GH axis · 7 Jul 2024 · 7 likes Taking the opening post at face value and following it one step further. Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well…